🚨The Risk of Mild, Moderate and Severe Infections in #IBD – Prospective multicentre cohort study (PRIQ)
📌Understudied topic
💎In 629 pts, we found mild & moderate infections are common & linked to key risk factors (steroids doubled the risk👀)
@JCC_IBD https://t.co/588htbPIcx
Delighted to finally get this paper over the line after working on it for so long. A huge collaborative effort. Thanks for all your help @DM_Simadibrata
(1/4) Happy to share a recently published study 🔥 off the press in JCC!
https://t.co/P6w89Kpsu9
We utilized ePROMs data collected from the TrueColours-#IBD to develop an escalation of therapy or intervention calculator for #UlcerativeColitis patients
@OUH_research#GITwitter
@TomDent_@azwah Much appreciated, very sorry you can't make the show, hope you catch it before it finishes or there's another run! Big fan of media molecule btw.
@TomDent_@azwah Hello Mr Dent, that's very kind of you to let me know but I managed to find a couple of tickets elsewhere, I had a feeling yours were all gone! If you find yourself needing to shift them quickly they seem to go almost instantly on the resale sites (twickets, ticketswap).
Introduction to advanced therapies in IBD
My talk to the surgeons @ACPGBI today @eicc
🧵 covering:
• therapeutic targets
• treatment strategies
• therapeutic ceiling
• early effective therapies in Crohn's
• the pros and cons of anti-TNF
• new small molecules for UC
@Jane1Ogden@AlisonEadie_ Hi Jane!!! 👋 Funnily enough I think Alison and I met a while back on a call with @health_psych_uk! But yes if you need any info Alison I'm more than happy to help. Using PROMs for IBD in Oxford!
@drkeithsiau More PROMs collection to allow for more efficient appointment allocation? Well patients could then be transferred to telemed clinic to create less footfall. Lots of patients travel for in person appts that they don't really need or want.
@NJPWext hey Danny, love the extension but can't seem to start a viewing party, I just get a constant spinning circle when waiting for a code, any ideas?